Related Experiment Video
Updated: Sep 12, 2025

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.7K
Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin Resistance
Pierre Gashema1,2, Aileen Jordan1, Eric Saramba3
1College of Medicine and Veterinary Medicine, University of Edinburgh.
Medrxiv : the Preprint Server for Health Sciences
|August 8, 2025
Summary
Despite high malaria knowledge in Rwanda, poor treatment adherence among febrile patients is a significant concern. This lack of adherence exacerbates the risk of antimalarial drug resistance, necessitating urgent interventions.
Area of Science:
- Public Health
- Infectious Diseases
- Global Health
Background:
- Prompt malaria diagnosis and treatment are vital interventions.
- Emerging artemisinin resistance in Rwanda highlights the need for optimal community treatment practices.
- Community knowledge and adherence significantly influence malaria treatment outcomes.
Purpose of the Study:
- To examine malaria knowledge, attitudes, and practices (KAP) among febrile patients in Rwandan government clinics.
- To identify factors influencing malaria treatment practices and adherence.
- To address challenges in malaria treatment in the context of rising antimalarial resistance.
Main Methods:
- A cross-sectional study was conducted in six health facilities in moderate to high malaria transmission areas of Rwanda.
- 406 febrile patients or caregivers of children with fever were enrolled and interviewed using semi-structured questionnaires.
- Data collection occurred from December 2023 to February 2024.
Main Results:
- High malaria knowledge was observed: 81% identified symptoms, 72% understood transmission, and 74.6% knew control measures.
- Despite high knowledge, only 46% of those treated completed the full 3-day antimalarial course.
- Poor adherence (stopping treatment early or late) was prevalent, and 27% took antimalarials for fever, often obtained from drug outlets.
Conclusions:
- High malaria knowledge in Rwanda does not translate to consistent treatment adherence.
- Poor adherence to antimalarial medication regimens is a critical factor contributing to the risk of drug resistance.
- Effective interventions are urgently required to improve antimalarial adherence in sub-Saharan Africa, especially where resistance is documented.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
239
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
239
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

